Genome-wide haplotype association study identifies BLM as a risk gene for prostate cancer in Chinese population

Nanoways to overcome docetaxel resistance in prostate cancer

(2014) Aditya Ganju et al.   DRUG RESISTANCE UPDATES

Influence of family history on psychosocial distress and perceived need for treatment in prostate cancer survivors

(2014) Andreas Dinkel et al.   Familial Cancer

ERBB4 Promoter Polymorphism Is Associated with Poor Distant Disease-Free Survival in High-Risk Early Breast Cancer

(2014) Kari J. Kurppa et al.   PLoS One

Current state of practice regarding testosterone supplementation therapy in men with prostate cancer

(2014) Jason R. Kovac et al.   STEROIDS

A novel in silico reverse-transcriptomics-based identification and blood-based validation of a panel of sub-type specific biomarkers in lung cancer

(2013) Debmalya Barh et al.   BMC GENOMICS

BLM and RAD51 Genes Polymorphism and Susceptibility to Breast Cancer

(2013) Agnieszka Sassi et al.   PATHOLOGY & ONCOLOGY RESEARCH

Genetic variation in genes involved in hormones, inflammation and energetic factors and breast cancer risk in an admixed population

(2012) M. L. Slattery et al.   CARCINOGENESIS

A role for p21-activated kinase 7 in the development of gastric cancer

(2012) Jun Gu et al.   FEBS Journal

High prevalence and breast cancer predisposing role of the BLM c.1642 C>T (Q548X) mutation in Russia

(2011) Anna P. Sokolenko et al.   INTERNATIONAL JOURNAL OF CANCER

Distinct Genomic Alterations in Prostate Cancers in Chinese and Western Populations Suggest Alternative Pathways of Prostate Carcinogenesis

(2010) X. Mao et al.   CANCER RESEARCH

Integrating common and rare genetic variation in diverse human populations

(2010)   NATURE

ENDEAVOUR update: a web resource for gene prioritization in multiple species

(2008) L.-C. Tranchevent et al.   NUCLEIC ACIDS RESEARCH